Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancerYun Gyoung Kim, Woo Chul Noh|Oncotarget|2017Cited by 15
A nationwide, multicenter retrospective study on the effectiveness and safety of eribulin in Korean breast cancer patients (REMARK)Min Ho Park, Joon Jeong, Woo Chul Noh et al.|The Breast|2020Cited by 2